| 2024 | 2023 | 2022 | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -105,2 k € | -186.7% | 121,3 k € | +151.2% | -236,9 k € | -96.8% | -120,4 k € | -132.4% | 371,7 k € | |
| EBITDA | -768,0 k € | -213.7% | -244,8 k € | +57.2% | -572,2 k € | -86.2% | -307,3 k € | -187.9% | 349,4 k € | |
| Operating profit | -964,0 k € | -121.0% | -436,2 k € | +41.4% | -744,4 k € | -107.8% | -358,2 k € | -202.8% | 348,3 k € | |
| Profit/loss | -986,9 k € | -117.8% | -453,2 k € | +41.0% | -768,1 k € | -107.1% | -370,8 k € | -210.6% | 335,4 k € | |
| Equity | -337,0 k € | -151.9% | 649,8 k € | +139.4% | 271,4 k € | -73.9% | 1,0 M € | +24.4% | 835,4 k € | |
| Total assets | 1,1 M € | -22.1% | 1,4 M € | +20.1% | 1,2 M € | -46.8% | 2,2 M € | +62.6% | 1,4 M € | |
| Cash | 162,8 k € | -75.8% | 672,2 k € | +96.4% | 342,3 k € | -58.6% | 826,1 k € | -35.8% | 1,3 M € | |
| Debts | 1,2 M € | +53.2% | 776,5 k € | -15.2% | 915,7 k € | -23.2% | 1,2 M € | +122.0% | 537,4 k € | |
| Staff | 7,3 | — | 4,4 | 3 | 2 | |||||
Public limited company · Diepenbeek · incorporated on 20/08/2019 · 7,3 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-75.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2292355864 | SIMABS | Agoralaan Abis, 3590 Diepenbeek |
| 2378436337 | SIMABS | Wetenschapspark 9, 3590 Diepenbeek |
SIMABS is a Public limited company incorporated in 2019. Its main activity is: Fabrication de médicaments. Its registered office is in Diepenbeek. It employs on average 7,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette